Back

Prognostic impact of natriuretic peptide value in patients with symptomatic and asymptomatic severe aortic stenosis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Myocardial damage and aortic stenosis: a close interplay Aortic Valve Stenosis ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Ryosuke Murai

Kobe City Medical Center General Hospital, Kobe (Japan)

6 More presentations in this session

Presentation thumbnail
Myocardial fibrosis and outcome in aortic stenosis: a CMR and circulating biomarker study
Associate Professor A. Gonzalez Miqueo (Pamplona, ES)
Abstract Slides Video
Presentation thumbnail
Cardiac damage stages and clinical outcomes in patients with severe aortic stenosis
Doctor Y. Takeji (Kanazawa, JP)
Abstract Slides Video
Presentation thumbnail
Evaluating the impact of left ventricular end-systolic elastance on aortic stenosis
Doctor E. Thong (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Comparative outcomes of early intervention vs. watchful waiting strategy for moderate aortic stenosis by extent of extra-valvular cardiac damage
Doctor J. Lim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of heart failure as an indication for intervention in severe aortic stenosis
Miss A. Cristea (Valladolid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Myocardial damage and aortic stenosis: a close interplay

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Association of circulating procollagen 1 N-terminal pro-peptide (P1NP) with clinical outcomes in asymptomatic patients with non-severe aortic valve stenosis: a post-hoc study of the SEAS trial
thumbnail
Congress Session
Advanced echocardiography for risk stratification in valve disease
thumbnail
Congress Presentation
Clinical Implications of NT-proBNP trajectory following Sacubitril/Valsartan initiation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources